)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Sichuan Kelun-Biotech Biopharmaceutical (6990) investor relations material
Sichuan Kelun-Biotech Biopharmaceutical H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary18 Aug, 2025
Executive summary
Revenue for the six months ended June 30, 2025, was RMB950.4 million, down 31.3% year-over-year, mainly due to lower milestone payments from license and collaboration agreements.
Net loss for the period was RMB145.2 million, compared to a profit of RMB310.2 million in the prior year; adjusted loss was RMB69.4 million.
Commercial sales reached RMB309.8 million, with sac-TMT accounting for 97.6% of sales.
Achieved significant commercialization milestones with multiple product launches and regulatory approvals in oncology and immunology, including first-in-class ADCs and mAbs for lung, breast, and nasopharyngeal cancers.
Expanded global clinical collaborations, notably with MSD, and out-licensed key assets for international development.
Financial highlights
Gross profit for 1H25 was RMB660.0 million, with gross margin at 69.4%, down from 77.9% year-over-year.
R&D expenses for 1H25 totaled RMB611.5 million, reflecting ongoing investment in pipeline development.
Selling and distribution expenses rose 334.8% to RMB178.9 million due to expanded commercialization.
Cash and financial assets totaled RMB4,527.8 million as of June 30, 2025, up 47.2% from year-end 2024.
No borrowings; net cash from financing activities was RMB1.77 billion, primarily from a June 2025 share placement.
Outlook and guidance
Focus on advancing differentiated pipelines targeting high medical need indications, especially in oncology and non-oncology diseases.
Plans to launch trastuzumab botidotin in China and file NDA for A400 in H2 2025.
Continued investment in R&D, AI-enabled drug discovery, and expansion of global partnerships.
Ongoing efforts to optimize commercialization strategies and expand market access, with sales revenue target for 2025 at RMB1 billion.
Anticipates reduced sales expenses ratio after inclusion in national medical insurance.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Sichuan Kelun-Biotech Biopharmaceutical earnings date
H2 202523 Mar, 2026
Next Sichuan Kelun-Biotech Biopharmaceutical earnings date
H2 202523 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a China-based company engaged in the research, development, and manufacturing of biopharmaceutical products. The company focuses on innovative therapeutics across various medical fields, including oncology, infectious diseases, and autoimmune disorders. It develops biologic drugs and biosimilars, utilizing advanced biotechnological platforms to address unmet medical needs. Sichuan Kelun-Biotech serves both domestic and international pharmaceutical markets. The company is headquartered in Chengdu, China, and its shares are listed on the Hong Kong Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage